NASDAQ:BBLG Bone Biologics (BBLG) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free BBLG Stock Alerts $1.81 +0.05 (+2.84%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$1.65▼$1.8350-Day Range$1.53▼$2.5752-Week Range$1.46▼$72.00Volume8,781 shsAverage Volume93,646 shsMarket Capitalization$959,300.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Bone Biologics alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Bone Biologics Stock (NASDAQ:BBLG)Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Read More BBLG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBLG Stock News HeadlinesMay 9, 2024 | americanbankingnews.comHead-To-Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Coloplast A/S (OTCMKTS:CLPBY)March 6, 2024 | businesswire.comBone Biologics Announces Closing of $2.0 Million Public OfferingMay 9, 2024 | Gold Safe Exchange (Ad)Gold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.March 4, 2024 | businesswire.comBone Biologics Announces Pricing of $2.0 Million Public OfferingMarch 1, 2024 | businesswire.comBone Biologics Reports Progress With NB1 Clinical ProgramJanuary 10, 2024 | finance.yahoo.comBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsDecember 28, 2023 | benzinga.comTrump-Linked SPAC Digital World Acquisition, Bone Biologics, Redwood Trust, Baidu, Tesla — Why These 5 Stocks Are On Investors' Radars TodaySee More Headlines Receive BBLG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:BBLG Previous SymbolNASDAQ:BBLG CUSIPN/A CIK1419554 Webwww.bonebiologics.com Phone781-552-4452FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($49.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,950,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-236.06% Return on Assets-154.82% Debt Debt-to-Equity RatioN/A Current Ratio4.50 Quick Ratio4.50 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$7.42 per share Price / Book0.24Miscellaneous Outstanding Shares530,000Free Float465,000Market Cap$959,300.00 OptionableNot Optionable Beta0.24 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Jeffrey Frelick (Age 58)CEO & President Comp: $325kMs. Deina H. Walsh (Age 60)Chief Financial Officer Comp: $212.5kDr. Shun'ichi KurodaCo-Founder & Member of Scientific Advisory BoardKey CompetitorsSientraNASDAQ:SIENQNanoVibronixNASDAQ:NAOVAcorda TherapeuticsNASDAQ:ACORQEvofem BiosciencesNASDAQ:EVFMSunshine BiopharmaNASDAQ:SBFMView All CompetitorsInsidersDeina H WalshBought 1,000 shares on 9/13/2023Total: $5,120.00 ($5.12/share)Jeff FrelickBought 1,187 shares on 9/11/2023Total: $6,552.24 ($5.52/share)Deina H WalshBought 875 shares on 9/6/2023Total: $4,970.00 ($5.68/share)Jeff FrelickBought 950 shares on 8/31/2023Total: $5,016.00 ($5.28/share)View All Insider Transactions BBLG Stock Analysis - Frequently Asked Questions How have BBLG shares performed in 2024? Bone Biologics' stock was trading at $4.52 at the start of the year. Since then, BBLG stock has decreased by 60.0% and is now trading at $1.81. View the best growth stocks for 2024 here. Are investors shorting Bone Biologics? Bone Biologics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 13,000 shares, a decline of 13.9% from the March 31st total of 15,100 shares. Based on an average daily volume of 80,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, 2.6% of the company's shares are sold short. View Bone Biologics' Short Interest. When is Bone Biologics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our BBLG earnings forecast. When did Bone Biologics' stock split? Bone Biologics shares reverse split before market open on Wednesday, December 20th 2023. The 1-8 reverse split was announced on Wednesday, December 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, December 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. When did Bone Biologics IPO? Bone Biologics (BBLG) raised $8 million in an initial public offering on Wednesday, October 13th 2021. The company issued 1,510,455 shares at $5.25 per share. How do I buy shares of Bone Biologics? Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BBLG) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.